17 Capital Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
17 Capital Partners's NVS Position: Q4 2021 in Review
17 Capital Partners sold out of Novartis (NVS) in Q4 2021, closing a stake of 10,768 shares — an estimated $881K sold.
17 Capital Partners first reported a position in NVS in Q2 2021 and held it in 2 quarters. The position peaked at $982K in Q2 2021. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.
- 17 Capital Partners reported no remaining Novartis position as of Q4 2021 after selling out during the quarter.
- 17 Capital Partners sold 10,768 Novartis shares in Q4 2021, an estimated $881K.
- 17 Capital Partners first reported a position in Novartis in Q2 2021 and held it in 2 quarters.
- 17 Capital Partners's Novartis position peaked at $982K in Q2 2021.
- 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.
Based on 17 Capital Partners's 13F filing for Q4 2021, filed 14 Jan 2022.